MGLRX | TARZX | MGLRX / TARZX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 12 years | 7 years | - |
Gain YTD | 2.475 | 16.651 | 15% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 25000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.39B | 329M | 726% |
Annual Yield % from dividends | 1.94 | 1.39 | 140% |
Returns for 1 year | 14.72 | 29.16 | 50% |
Returns for 3 years | -18.12 | -9.80 | 185% |
Returns for 5 years | 5.21 | -8.53 | -61% |
Returns for 10 years | 34.47 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IMCGX | 10.58 | N/A | N/A |
Transamerica Mid Cap Growth I | |||
PAIOX | 8.12 | N/A | N/A |
PGIM Jennison Intl Sm-Md Cap Opps R6 | |||
WSTRX | 54.13 | -0.28 | -0.51% |
Delaware Ivy Science and Technology R | |||
TEMUX | 13.90 | -0.11 | -0.79% |
Morgan Stanley Pathway Em Mkts Eq | |||
QCSCX | 22.12 | -0.19 | -0.85% |
Federated Hermes MDT Small Cap Core C |